Leserbrief
Leprosy—Insufficient Evidence for Monthly Multidrug Therapy—Reply
JAMA Dermatology · 2024
DOI: 10.1001/jamadermatol.2024.1339 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA Dermatology, 2024. Verfasst von Victoria J Shi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Missouri-Kansas City School of Medicine, Kansas City. Hauptthemen laut MEDLINE: Leprosy, Leprostatic Agents, Drug Therapy, Combination. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
LeprosyLeprostatic AgentsDrug Therapy, CombinationHumansDrug Administration ScheduleEvidence Gaps
Substanzen
Leprostatic Agents
Autor:innen und Institutionen
- Department of Dermatology, University of Missouri-Kansas City School of Medicine, Kansas City.
Zitieren
APA
Shi, V. J., Poondru, S., & Rajpara, A. (2024). Leprosy—Insufficient Evidence for Monthly Multidrug Therapy—Reply. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2024.1339
Vancouver
Shi VJ, Poondru S, Rajpara A. Leprosy—Insufficient Evidence for Monthly Multidrug Therapy—Reply. JAMA Dermatology. 2024. doi:10.1001/jamadermatol.2024.1339
BibTeX
@article{Shi2024,
author = {Shi, Victoria J and Poondru, Sneha and Rajpara, Anand},
title = {Leprosy—Insufficient Evidence for Monthly Multidrug Therapy—Reply},
journal = {JAMA Dermatology},
year = {2024},
doi = {10.1001/jamadermatol.2024.1339}
}
EUVIMED